A PAM50-Based Chemoendocrine Score for Hormone Receptor-Positive Breast Cancer with an Intermediate Risk of Relapse.

Autor: Prat A; Department of Medical Oncology, Hospital Clínic i Provincial, Barcelona, Spain. alprat@clinic.ub.es.; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Lluch A; Department of Medical Oncology, Valencia University Hospital, Valencia, Spain., Turnbull AK; University of Edinburgh Cancer, Research UK Centre, Edinburgh., Dunbier AK; Department of Biochemistry, University of Otago, Dunedin, New Zealand., Calvo L; Department of Medical Oncology, A Coruña University Hospital Complex, A Coruña, Spain., Albanell J; Department of Medical Oncology, Hospital del Mar Medical Research Institute-IMIM and Pompeu Fabra University, Barcelona, Spain., de la Haba-Rodríguez J; Department of Medical Oncology, Biomedical Research Institute-IMIBIC, Reina Sofía Hospital Complex, Córdoba, Spain., Arcusa A; Department of Medical Oncology, Consorci Sanitari de Terrassa, Barcelona, Spain., Chacón JI; Department of Medical Oncology, Virgen de la Salud Hospital, Toledo, Spain., Sánchez-Rovira P; Department of Medical Oncology, Jaén Hospital Complex, Jaen, Spain., Plazaola A; Department of Medical Oncology, Onkologikoa, Donostia, Spain., Muñoz M; Department of Medical Oncology, Hospital Clínic i Provincial, Barcelona, Spain.; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Paré L; Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Parker JS; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina., Ribelles N; Department of Medical Oncology, Virgen de la Victoria University Hospital, Málaga, Spain., Jimenez B; Department of Medical Oncology, Virgen de la Victoria University Hospital, Málaga, Spain., Bin Aiderus AA; University of Edinburgh Cancer, Research UK Centre, Edinburgh., Caballero R; GEICAM (Spanish Breast Cancer Research Group), Madrid, Spain., Adamo B; Department of Medical Oncology, Hospital Clínic i Provincial, Barcelona, Spain.; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Dowsett M; Academic Department of Biochemistry, Royal Marsden Foundation Trust, London, United Kingdom., Carrasco E; GEICAM (Spanish Breast Cancer Research Group), Madrid, Spain., Martín M; Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain., Dixon JM; University of Edinburgh Cancer, Research UK Centre, Edinburgh., Perou CM; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.; Department of Genetics, University of North Carolina, Chapel Hill, North Carolina.; Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina., Alba E; Department of Medical Oncology, Virgen de la Victoria University Hospital, Málaga, Spain.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2017 Jun 15; Vol. 23 (12), pp. 3035-3044. Date of Electronic Publication: 2016 Nov 30.